Lombard Medical (EVARF) Stock Price, News & Analysis

Company Overview

Lombard Medical, Inc. (OTCMKTS: EVARF) is a medical device company focused on the development of minimally invasive endovascular systems for the treatment of aortic aneurysms. The company’s technology is designed to offer an alternative to traditional open surgery by sealing aneurysms within the vessel walls, reducing the risk of rupture and improving patient recovery times.

The company’s flagship product is the Nellix EndoVascular Aneurysm Sealing (EVAS) System, which combines balloon-expandable stents encased in polymer-filled endobags to conform to patient anatomy and seal aneurysm sacs. Lombard Medical has pursued regulatory approvals and clinical studies to demonstrate the safety and efficacy of Nellix, including an investigational device exemption (IDE) study in the United States and CE mark clearance in Europe.

Headquartered in Santa Clara, California, Lombard Medical serves interventional radiologists, vascular surgeons and hospitals across North America and Europe. The company’s leadership team brings together professionals with extensive experience in vascular medicine, regulatory affairs and medical device commercialization. Lombard Medical continues to advance its product pipeline and expand clinical adoption of its endovascular aneurysm sealing technology.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 10/27/2016
• Today: 9/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:EVARF
• Previous Symbol: NASDAQ:EVAR
• CIK: N/A
• Web: www.lombardmedical.com
• Phone: 44121235750800
• Fax: 44-0-12-3575-0879
• Employees: 111
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A